期刊文献+

噬血细胞综合征患者血清LDH和β_2-MG检测的临床意义 被引量:2

下载PDF
导出
摘要 目的探讨噬血细胞综合征(HPS)患者血清乳酸脱氢酶(LDH)和血清β2-微球蛋白(β2-MG)测定的临床意义。方法分别采用速率法和放免法测定31例HPS患者和17名正常对照者血清LDH和β2-MG水平。结果正常对照组与HPS组、HPS治疗缓解组与初发组、非肿瘤相关性HPS(NT-HPS)与肿瘤相关性HPS(T-HPS)组的β2-MG水平相比,后者均明显高于前者(P<0.05);而LDH在前2组中差异有统计学意义(P<0.05),但在NT-HPS和T-HPS之间差异无统计学意义(P>0.05)。结论β2-MG和LDH的检测有助于HPS诊断和疗效的评价。而且β2-MG还可以作为鉴别NT-HPS和T-HPS的一个辅助指标。
出处 《检验医学》 CAS 北大核心 2010年第10期807-809,共3页 Laboratory Medicine
基金 浙江省科技厅资助项目(2007C33083) 浙江省自然基金资助项目(Y2080353) 杭州市科技局资助项目(20090833B24 20070114 2008CA031)
  • 相关文献

参考文献10

  • 1王学文.噬血细胞综合征研究进展[J].国外医学(输血及血液学分册),1998,21(6):353-357. 被引量:37
  • 2Kaito K,Kobayashi M,Katayama T,et al.Prognostic factors of hemophagocytic syndrome in adults:analysis of 34 cases[J].Eur J Haematol,1997,59(4):247-253.
  • 3钱江潮,周海霞,阮积晨,王菊香.噬血细胞综合征临床和治疗[J].中国小儿血液,2004,9(3):116-118. 被引量:2
  • 4Schneider EM,Lorenz I,Müller-Rosenberger M,et al.Hemophagocytic lymphohistiocytosis is associated with deficiencies of cellular cytolysis but normal expression of transcripts relevant to killer-cell-induced apoptosis[J].Blood,2002,100(8):2891-2898.
  • 5张莉娟,谢元芳,盛慧球,明道化.NHL血清LDH及β_2-微球蛋白测定的临床意义[J].临床血液学杂志,2004,17(3):128-129. 被引量:8
  • 6Nahum E,Ben-Ari J,Stain J,et al.Hemophagocytic lymphohistiocytic syndrome:unrecognized cause of multiple organ failure[J].Pediatr Crit Care Med,2000,1(1):51-54.
  • 7Nomura T,Huang WC,Seo S,et al.Targeting beta2-microglobulin mediated signaling as a novel therapeutic approach for human renal cell carcinoma[J].J Urol,2007,178(1):292-300.
  • 8Tichy M,Maisnar V.Laboratory identification of mo-noclonal immunoglobin[J].Vnitr Lek,2006,52(Suppl 2):41-45.
  • 9Nagura E.Prognositic factors in multiple myeloma[J].Nippon Rinsho,2007,65(12):2351-2356.
  • 10Tong H,Ren Y,Liu H,et al.Clinical characteristics of T-cell lymphoma associated with hemophagocytic syndrome:comparison of T-cell lymphoma with and without hemophagocytic syndrome[J].Leuk Lymphoma,2008,49(1):81-87.

二级参考文献16

  • 1张之南 忱悌.血液病诊断及疗效标准(第2版)[M].北京:科学出版社,1999.270-271.
  • 2Hahn J S, Lee S,Chong S Y, et al. Eight-year experience of malignant lymphoma-survival and pronostic factors. Yonsei Med J, 1997,38:270-284.
  • 3Morra E. The biological markers of non-Hodgkin′s lymphomas: their role in diagnostic assessment and therapeutic strategy. Int J Biol Markers, 1999,14:149- 153.
  • 4Benboubker L,Valat C,Linassier C, et al . A new serologic index for low-grade non-Hodgkin′s lymphoma based on initial CA125 and LDH serum levels. Ann Onco1,2000,11:1485- 1491.
  • 5Janka G, Imashuku S, Elinda G, et al. Infection and lignant associated hemaphagocytic syndromes. Secondary hemophagocytic lymphohistiocytosis. In: Egeler RM, D' Angio GJ, editors. Hematology/oncology clinics of North America. Philadelphi a: WBS aunders CO
  • 6Henter JH, Elinder G, Ost A. The FHL study group of histiocyte Societ y: Diagnostic guideline for hemophagocytic lymphohistoiocytosis. Semin Oncol, 19 91;18:29.
  • 7Kerquenec C, Hillare S, Molinie V, et al. Hepaticmanifestations of hemophagocytic syndromes. A Study of 30 cases. Am J Gastrol, 2001;96:852.
  • 8Cruz AM, Camas RS, Ramirez OP, et al. Hemophagocytic syndrome associated with hematological neoplasias. Leuk Res., 1998;22:369.
  • 9Kogawa K, Lee SM, Villanueva J, et al. Perform expression in cytotoxic lymphocytes from patients with hemophagocytic lymphohistiocytosis and their family mem bers. Blood, 2002;99(1):61.
  • 10Yang FC, Yabuhara A, Koike K, et al. Functional abnormalities of natural killer cells in childhood hemophagocytic syndrome. Nihon Rinsho Meneki Gakkai Kaishi , 1995;18(1):36.

共引文献44

同被引文献32

  • 1Filipovich AH.Life-threatening hemophagocytic syndromes:currentoutcomes with hematopoietic stem cell transplantation[J].Pediatrtransplant,2005,9(Suppl 7):87-91.
  • 2Verbsky JW,Grossman WJ.Hemophagoeytic lymphohistiocytosis:diagnosis,pathophysiology,treatment and future perspectives[J].Ann Med,2006,38(1):20-31.
  • 3Mien M,De Fusco C,Legrand F,et a1.Familial hemophagocyticlymphohistiecytosi:how late can the onset be?[J].Haenlatologica,2001,86(5):499-503.
  • 4Arie M,Danesino C,Pende D,et a1.Pathogenesis of haemophagoeyticlymphohistiocytosis[J].Br J Haematol,2001,l14(3):761-769.
  • 5Rudd E,G ransdotter Ericson K,Zheng C,et a1.Spectrum and clinicalimplications of syntaxin ll gene mutations in familial haemophagocyticlymphohistiocytosis:association with disease-free remissions andhaematopoietic malignancies[J].J Med Genet,2006,43(4):14.
  • 6SchneiderEM,LorenzL,Muller-RosenbergerM,eta1.Hemophagoeyticv lymphohistiecytosis is associated with deficiencies of cdluhr cytolysisbut norlnal expression of transcripts relevant to killer-cell-inducedapoptesis[J].Blood,2002,100(11):2891-2898.
  • 7de Saint Basile G,Fischer A.Defective cytotoxic granule-mediatedcell death pathway impairs T lymphocyte homeostasis[J].Curr Opin Rheumatoid,2003,15(4):436-445.
  • 8Janka G.Familial and acquired hemophagocytie lymphohistioeytosis[J].Eur J Pediatr,2007,166(2):95-109.
  • 9Henter JI,HonIe AC,Egeler RM,et a1.HLH-2004:Diagnostic and华西医学2012,27(2)West China Medical Journal,Vol.27,No.2Feb.2012205therapeutic guidelines for hemophagocytic lymphohistiocytosis[J].Pediatr B1ood Cancer,2007(48):124-131.
  • 10Janka G.Hemophagucytie syndromes[J].Blood Rev,2007,21(5):245-253.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部